Innocoll Holdings Limited
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Innocoll Holdings Limited
Keeping Track: Gavreto, Sogroya Bring Annual CDER Novel Approvals To 40; New Analgesic Products Make It Past US FDA
The latest drug approval news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Sixteen applications are in line for US FDA decisions in August. Ten are novel agents.
The latest drug development news and highlights from our US FDA Performance Tracker.
Among the antibiotics that have garnered a qualified infectious disease product designation, a collection of late-stage products are targeted at local delivery, especially inhaled and vaginal formulations.
- Drug Delivery
- Specialty Pharmaceuticals
- Site Specific
- Topical Delivery
- Implantable Devices
- Other Names / Subsidiaries
- Gurnet Point L.P.
- Innocoll Pharmaceuticals Limited
- Innocoll Inc
- Innocoll Biotherapeutics plc